VenovaNovember 6, 2025Venova Medical Announces First Subjects Enrolled in VENOS-3 Pivotal IDE Study of the Velocity® Percutaneous AVF System
VenovaSeptember 4, 2024Venova Medical Announces $30 Million Series B Financing and Appointment of New Board Member
